Benitec Biopharma (BNTC) Operating Leases (2019 - 2025)
Benitec Biopharma (BNTC) posted Operating Leases of $519000.0 for Q4 2025, up 28.78% sequentially from $403000.0 in Q3 2025, and up 278.83% YoY from $137000.0 in Q4 2024.
Benitec Biopharma (BNTC) Operating Leases (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Operating Leases for 7 years, with the latest figure at $519000.0 in Q4 2025.
- Quarterly Operating Leases rose 278.83% year-over-year to $519000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $519000.0 (up 278.83% YoY) and the FY2025 annual result came in at $495000.0, changed N/A from the prior year.
- Operating Leases rose to $519000.0 in Q4 2025 per BNTC's latest filing, from $403000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $954000.0 in Q3 2021 and troughed at $54000.0 in Q1 2021.
- A 5-year average of $449157.9 and a median of $422000.0 in 2022 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2022 and 2023: Operating Leases surged 1075.93% in 2022, then slumped 67.54% in 2023.
- Over 5 years, Operating Leases stood at $698000.0 in 2021, then slumped by 39.54% to $422000.0 in 2022, then slumped by 67.54% to $137000.0 in 2023, then changed by 0.0% to $137000.0 in 2024, then jumped by 278.83% to $519000.0 in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $519000.0, $403000.0, and $495000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 519,000.00 |
| Sep 30, 2025 | 403,000.00 |
| Jun 30, 2025 | 495,000.00 |
| Mar 31, 2025 | 613,000.00 |
| Dec 31, 2024 | 137,000.00 |
| Sep 30, 2024 | 211,000.00 |
| Mar 31, 2024 | 354,000.00 |
| Dec 31, 2023 | 137,000.00 |
| Sep 30, 2023 | 491,000.00 |
| Jun 30, 2023 | 284,000.00 |
| Mar 31, 2023 | 354,000.00 |
| Dec 31, 2022 | 422,000.00 |
| Sep 30, 2022 | 749,000.00 |
| Jun 30, 2022 | 811,000.00 |
| Mar 31, 2022 | 635,000.00 |
| Dec 31, 2021 | 698,000.00 |
| Sep 30, 2021 | 954,000.00 |
| Jun 30, 2021 | 213,000.00 |
| Mar 31, 2021 | 54,000.00 |
| Dec 31, 2020 | 108,000.00 |